Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-lipoic acid and glucosamine hydrochloride for early primary osteoarthritis
ChiCTR2500096537Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alpha-lipoic acid and glucosamine sulphate in osteoarthritis (OA) (4 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Visual Analogue Scale, Lequesne Algofunctional Index and 1 more. Started Jan 2025; status: recruiting.
02
Drugs
alpha-lipoic acidglucosamine sulphate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500096537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096537.